The physician has ordered combination therapy for the client with Helicobacter pylori. The nurse plans to do medication education. What will the best plan by the nurse include?

A. The patient's understanding of the medication:

While it's important for the patient to understand their medication, assessing their understanding is typically done through patient education and counseling. This assessment is vital for promoting adherence and safe medication practices but is not the primary consideration immediately before administration.

B. The patient's ability to swallow:

This is the correct answer. Assessing the patient's ability to swallow is crucial before administering oral medications to ensure that the patient can safely and effectively take the prescribed medication without the risk of aspiration or choking.

C. The patient's allergies:

Assessing the patient's allergies is an essential step in medication administration, but it is generally part of the overall medication safety process. It may not be the primary assessment immediately before administering an oral medication, but it is a crucial consideration.

D. The eyesight:

The patient's eyesight is not typically a primary assessment before administering oral medications. While visual impairments can affect a patient's ability to read medication labels or instructions, it is not the immediate concern when assessing readiness for oral medication administration.

A. Combination therapy has the best outcomes when omeprazole, propranolol, bismuth salicylate are used.

Propranolol is not an antibiotic and is not part of the standard combination therapy for H. pylori. Bismuth subsalicylate may be used in some regimens, but the standard involves a proton pump inhibitor, clarithromycin, and amoxicillin or metronidazole.

B. Combination therapy has the best outcomes when omeprazole, clarithromycin, and amoxicillin are used.

This is the correct choice. The standard combination therapy for H. pylori infection includes a proton pump inhibitor (such as omeprazole), clarithromycin, and amoxicillin or metronidazole.

C. The use of sucralfate along with antibiotics is the best combination therapy for peptic ulcer disease.

Sucralfate is not typically part of the standard antibiotic combination therapy for H. pylori. It is a cytoprotective agent that may be used to treat ulcers but is not a primary component in eradicating H. pylori.

D. Various antibiotics are used to eradicate the bacteria that are responsible for the development of peptic ulcer disease.

While this statement is true, it does not specify the standard combination therapy. The most common antibiotics used in combination therapy for H. pylori include clarithromycin and amoxicillin or metronidazole, along with a proton pump inhibitor.